SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories reports 51% jump in export sales revenue in Q4FY19

06 May 2019 Evaluate

Morepen Laboratories has reported export sales revenue up by 51% at Rs 96.41 crore due to high impetus in API business for Q4FY19. The company’s domestic sales revenue up by 13% at Rs 118.84 crore.

Besides, the company’s API sales revenue grew by 34% at Rs 125.48 crore and Home Diagnostics Sales Revenue by 12% at Rs 27.77 crore in Q4FY19 and formulation sales revenue jumped by 30% at Rs 49.35 crore.

Morepen is a well-known pharma company having well equipped Research & Development Centre and is all set to seize the Generic revolution in pharma industry, by filing multiple DMFs and COS for new APIs.

Morepen Laboratories Share Price

60.50 -2.11 (-3.37%)
02-Jul-2026 12:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1876.10
Dr. Reddys Labs. 1350.05
Cipla 1462.75
Zydus Lifesciences 1099.85
Lupin 2391.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: